AAAAAA

   
Results: 1-23 |
Results: 23
Antecedents to hospital deaths
Authors: Hillman, KM Bristow, PJ Chey, T Daffurn, K Jacques, T Norman, SL Bishop, GF Simmons, G
Citation: Km. Hillman et al., Antecedents to hospital deaths, INTERN M J, 31(6), 2001, pp. 343-348
Raw oyster consumption and outbreaks of viral gastroenteritis in New Zealand: evidence for risk to the public's health
Authors: Simmons, G Greening, G Gao, WZ Campbell, D
Citation: G. Simmons et al., Raw oyster consumption and outbreaks of viral gastroenteritis in New Zealand: evidence for risk to the public's health, AUS NZ J PU, 25(3), 2001, pp. 234-240
Carriage of Neisseria meningitidis among household contacts of patients with meningococcal disease in New Zealand
Authors: Simmons, G Martin, D Stewart, J Jones, N Calder, L Bremner, D
Citation: G. Simmons et al., Carriage of Neisseria meningitidis among household contacts of patients with meningococcal disease in New Zealand, EUR J CL M, 20(4), 2001, pp. 237-242
Laparoscopic transverse hemicystectomy with ileocystoplasty in a porcine model
Authors: Lifshitz, DA Beck, SDW Barret, E Simmons, G Chang, L Lingeman, JE Shalhav, AL
Citation: Da. Lifshitz et al., Laparoscopic transverse hemicystectomy with ileocystoplasty in a porcine model, J ENDOUROL, 15(2), 2001, pp. 199-203
Phylogenetic analysis of multiple heterosexual transmission events involving subtype B of HIV type 1
Authors: Hayman, A Moss, T Simmons, G Arnold, C Holmes, EC Naylor-Adamson, L Hawkswell, J Allen, K Radford, J Nguyen-Van-Tam, J Balfe, P
Citation: A. Hayman et al., Phylogenetic analysis of multiple heterosexual transmission events involving subtype B of HIV type 1, AIDS RES H, 17(8), 2001, pp. 689-695
A chimeric MIP-1 alpha/RANTES protein demonstrates the use of different regions of the RANTES protein to bind and activate its receptors
Authors: Blanpain, C Buser, R Power, CA Edgerton, M Buchanan, C Mack, M Simmons, G Clapham, PR Parmentier, M Proudfoot, AEI
Citation: C. Blanpain et al., A chimeric MIP-1 alpha/RANTES protein demonstrates the use of different regions of the RANTES protein to bind and activate its receptors, J LEUK BIOL, 69(6), 2001, pp. 977-985
Evidence for a post-entry barrier to R5 HIV-1 infection of CD4 memory T cells
Authors: Vyakarnam, A Eyeson, J Teo, I Zuckerman, M Babaahmady, K Schuitemaker, H Shaunak, S Rostron, T Rowland-Jones, S Simmons, G Clapham, P
Citation: A. Vyakarnam et al., Evidence for a post-entry barrier to R5 HIV-1 infection of CD4 memory T cells, AIDS, 15(13), 2001, pp. 1613-1626
Changing risk behaviours for non-communicable disease in New Zealand working men - is workplace intervention effective?
Authors: Cook, C Simmons, G Swinburn, B Stewart, J
Citation: C. Cook et al., Changing risk behaviours for non-communicable disease in New Zealand working men - is workplace intervention effective?, NZ MED J, 114(1130), 2001, pp. 175-178
Development of multianalyte sensor arrays composed of chemically derivatized polymeric microspheres localized in micromachined cavities
Authors: Goodey, A Lavigne, JJ Savoy, SM Rodriguez, MD Curey, T Tsao, A Simmons, G Wright, J Yoo, SJ Sohn, Y Anslyn, EV Shear, JB Neikirk, DP McDevitt, JT
Citation: A. Goodey et al., Development of multianalyte sensor arrays composed of chemically derivatized polymeric microspheres localized in micromachined cavities, J AM CHEM S, 123(11), 2001, pp. 2559-2570
Carriage of N-lactamica in a population at high risk of meningococcal disease
Authors: Simmons, G Martin, D Stewart, J Bremner, D
Citation: G. Simmons et al., Carriage of N-lactamica in a population at high risk of meningococcal disease, EPIDEM INFE, 125(1), 2000, pp. 99-104
Equivalence of ceftriaxone and rifampicin in eliminating nasopharyngeal carriage of serogroup B Neisseria meningitidis
Authors: Simmons, G Jones, N Cader, L
Citation: G. Simmons et al., Equivalence of ceftriaxone and rifampicin in eliminating nasopharyngeal carriage of serogroup B Neisseria meningitidis, J ANTIMICRO, 45(6), 2000, pp. 909-911
Co-receptor use by HIV and inhibition of HIV infection by chemokine receptor ligands
Authors: Simmons, G Reeves, JD Hibbitts, S Stine, JT Gray, PW Proudfoot, AEI Clapham, PR
Citation: G. Simmons et al., Co-receptor use by HIV and inhibition of HIV infection by chemokine receptor ligands, IMMUNOL REV, 177, 2000, pp. 112-126
Tuberculosis: reasons for diagnostic delay in Auckland
Authors: Calder, L Gao, WZ Simmons, G
Citation: L. Calder et al., Tuberculosis: reasons for diagnostic delay in Auckland, NZ MED J, 113(1122), 2000, pp. 483-485
Whither the public health function?
Authors: Campbell, DM Simmons, G
Citation: Dm. Campbell et G. Simmons, Whither the public health function?, NZ MED J, 113(1120), 2000, pp. 448-449
T-cell line adaptation of human immunodeficiency virus type 1 strain SF162: effects on envelope, vpu and macrophage-tropism
Authors: Dejucq, N Simmons, G Clapham, PR
Citation: N. Dejucq et al., T-cell line adaptation of human immunodeficiency virus type 1 strain SF162: effects on envelope, vpu and macrophage-tropism, J GEN VIROL, 81, 2000, pp. 2899-2904
A small molecule antagonist of chemokine receptors CCR1 and CCR3 - Potent inhibition of eosinophil function and CCR3-mediated HIV-1 entry
Authors: Sabroe, I Peck, MJ Van Keulen, BJ Jorritsma, A Simmons, G Clapham, PR Williams, TJ Pease, JE
Citation: I. Sabroe et al., A small molecule antagonist of chemokine receptors CCR1 and CCR3 - Potent inhibition of eosinophil function and CCR3-mediated HIV-1 entry, J BIOL CHEM, 275(34), 2000, pp. 25985-25992
Differential activation of CC chemokine receptors by AOP-RANTES
Authors: Elsner, J Mack, M Bruhl, H Dulkys, Y Kimmig, D Simmons, G Clapham, PR Schlondorff, D Kapp, A Wells, TNC Proudfoot, AEI
Citation: J. Elsner et al., Differential activation of CC chemokine receptors by AOP-RANTES, J BIOL CHEM, 275(11), 2000, pp. 7787-7794
KSHV-encoded CC chemokine vMIP-III is a CCR4 agonist, stimulates angiogenesis, and selectively chemoattracts TH2 cells
Authors: Stine, JT Wood, C Hill, M Epp, A Raport, CJ Schweickart, VL Endo, Y Sasaki, T Simmons, G Boshoff, C Clapham, P Chang, Y Moore, P Gray, PW Chantry, D
Citation: Jt. Stine et al., KSHV-encoded CC chemokine vMIP-III is a CCR4 agonist, stimulates angiogenesis, and selectively chemoattracts TH2 cells, BLOOD, 95(4), 2000, pp. 1151-1157
Chemokine inhibition of HIV infection
Authors: Reeves, JD Simmons, G
Citation: Jd. Reeves et G. Simmons, Chemokine inhibition of HIV infection, METH MOL B, 138, 2000, pp. 209-222
HIV coreceptors, cell tropism and inhibition by chemokine receptor ligands
Authors: Clapham, PR Reeves, JD Simmons, G Dejucq, N Hibbitts, S McKnight, A
Citation: Pr. Clapham et al., HIV coreceptors, cell tropism and inhibition by chemokine receptor ligands, MOL MEMBR B, 16(1), 1999, pp. 49-55
Coreceptor ligand inhibition of fetal brain cell infection by HIV type 1
Authors: Hibbitts, S Reeves, JD Simmons, G Gray, PW Epstein, LG Schols, D De Clercq, E Wells, TNC Proudfoot, AEI Clapham, PR
Citation: S. Hibbitts et al., Coreceptor ligand inhibition of fetal brain cell infection by HIV type 1, AIDS RES H, 15(11), 1999, pp. 989-1000
Primary human immunodeficiency virus type 2 (HIV-2) isolates infect CD4-negative cells via CCR5 and CXCR4: Comparison with HIV-1 and simian immunodeficiency virus and relevance to cell tropism in vivo
Authors: Reeves, JD Hibbitts, S Simmons, G McKnight, A Azevedo-Pereira, JM Moniz-Pereira, J Clapham, PR
Citation: Jd. Reeves et al., Primary human immunodeficiency virus type 2 (HIV-2) isolates infect CD4-negative cells via CCR5 and CXCR4: Comparison with HIV-1 and simian immunodeficiency virus and relevance to cell tropism in vivo, J VIROLOGY, 73(9), 1999, pp. 7795-7804
Expanded tropism of primary human immunodeficiency virus type 1 R5 strainsto CD4(+) T-cell lines determined by the capacity to exploit low concentrations of CCR5
Authors: Dejucq, N Simmons, G Clapham, PR
Citation: N. Dejucq et al., Expanded tropism of primary human immunodeficiency virus type 1 R5 strainsto CD4(+) T-cell lines determined by the capacity to exploit low concentrations of CCR5, J VIROLOGY, 73(9), 1999, pp. 7842-7847
Risultati: 1-23 |